|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-10-8
|
|
pubmed:abstractText |
High usage of the neuraminidase inhibitor (NAI) oseltamivir in Japan since 2003 led the Neuraminidase Inhibitor Susceptibility Network to assess the susceptibility of community isolates of influenza viruses to oseltamivir and zanamivir.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
751-61
|
|
pubmed:meshHeading |
pubmed-meshheading:19812437-Antiviral Agents,
pubmed-meshheading:19812437-Drug Resistance, Viral,
pubmed-meshheading:19812437-Humans,
pubmed-meshheading:19812437-Influenza, Human,
pubmed-meshheading:19812437-Influenza A Virus, H3N2 Subtype,
pubmed-meshheading:19812437-Influenza B virus,
pubmed-meshheading:19812437-Japan,
pubmed-meshheading:19812437-Neuraminidase,
pubmed-meshheading:19812437-Sentinel Surveillance
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
|
|
pubmed:affiliation |
WHO Collaborating Center for Reference & Research on Influenza, National Institute of Infectious Diseases, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
